Stevens L M, Kumar R, Chen K W. "Method for the Synthesis of [1-(2-Chloro-acetyl)-piperidin-3-ylmethyl]-cyclopropyl-carbamic acid tert-butyl ester" [P]. US Patent, US 9842236 B2, 2017-02-13.
Davis P L, Anderson J P, Brown S R. "A Process for Preparing High-Purity [1-(2-Chloro-acetyl)-piperidin-3-ylmethyl]-cyclopropyl-carbamic acid tert-butyl ester" [P]. US Patent, US 11216814 B2, 2020-02-27.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 1770, (8), 5356-5384.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2023, 1974, (9), 6884-6893.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of [1-(2-Chloro-acetyl)-piperidin-3-ylmethyl]-cyclopropyl-carbamic acid tert-butyl ester Using HRMS and NMR". J. Chromatogr. A, 2014, 1910, (12), 351-362.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2021, 232, (6), 2282-2290.